Poole, Kenneth E. S.

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Poole, K. E. S., Van Bezooijen, R. L., Loveridge, N., Hamersma, H., Papapoulos, S. E., Löwik, C. W., & Reeve, J. (2005) · The FASEB Journal

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 965

UK clinical guideline for the prevention and treatment of osteoporosis

Gregson, C. L., Armstrong, D. J., Bowden, J., Cooper, C., Edwards, J., Gittoes, N. J. L., Harvey, N., Kanis, J., Leyland, S., Low, R., et al. (2022) · Archives of Osteoporosis

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 593

Whole-genome sequencing of patients with rare diseases in a national health system

Turro, E., Astle, W. J., Megy, K., Gräf, S., Greene, D., Shamardina, O., Allen, H. L., Sanchis-Juan, A., Frontini, M., Thys, C., et al. (2020) · Nature

Genomics and Rare DiseasesGenetic Associations and Epidemiology

Cited by 554

A cholinergic neuroskeletal interface promotes bone formation during postnatal growth and exercise

Gadomski, S., Fielding, C., García-García, A., Korn, C., Kapeni, C., Ashraf, S., Villadiego, J., Toro, R. D., Domingues, O., Skepper, J. N., et al. (2022) · Cell Stem Cell

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 65

Obesity is associated with early hip fracture risk in postmenopausal women: a 25-year follow-up

Rikkonen, T., Sund, R., Sirola, J., Honkanen, R., Poole, K. E. S., & Kröger, H. (2021) · Osteoporosis International

Bone health and osteoporosis researchHip and Femur Fractures

Cited by 52

Risedronate therapy for prevention of hip fracture after stroke in elderly women

Poole, K. E. S., Warburton, E. A., & Reeve, J. (2005) · Neurology

Bone health and osteoporosis researchHip and Femur Fractures

Cited by 13